Dayli Partners
Venture Capital, Accelerator/Incubator
Active
Seoul, South Korea
73
6M
58
1
0.21
6
- Areas of investment
Summary
We can highlight the next thriving fund investment areas, such as Medical Device, Internet. Moreover, a startup needs to be at the age of 6-10 years to get the investment from the fund. Among the most popular portfolio startups of the fund, we may highlight Curiox Biosystems, Alodokter. The fund has exact preference in a number of founders of portfolio startups.
The standard case for the fund is to invest in rounds with 6-7 partakers. Despite the Dayli Partners, startups are often financed by Lim Der Shing, Golden Gate Ventures, 500 Startups. The meaningful sponsors for the fund in investment in the same round are Softbank Ventures Asia, Sequis Life, SV Investment Partners.
Deals in the range of 10 - 50 millions dollars are the general things for fund. The fund is constantly included in 2-6 investment rounds annually. The important activity for fund was in 2019.
Investor highlights
- Industry focus
- Stage focus
- Geo focus
Discover reliable insights
Find relevant VC investors, identify key contacts and secure funding opportunities.
Investments analytics
Analytics
- Total investments
- 73
- Lead investments
- 1
- Exits
- 6
- Follow on index
- 0.21
- Investments by industry
- Biotechnology (48)
- Health Care (27)
- Medical (24)
- Pharmaceutical (20)
- Medical Device (10) Show 51 more
- Investments by region
-
- South Korea (68)
- United States (3)
- Indonesia (1)
- Singapore (1)
- Peak activity year
- 2021
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 8
- Avg. valuation at time of investment
- 5M
- Group Appearance index
- 0.53
- Avg. company exit year
- 10
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| JD Bioscience | 01 Jan 2021 | Biotechnology, Medical, Pharmaceutical, Biopharma | Seed | Gangwon-do, South Korea, South Korea | |
| Ubix Therapeutics | 01 Jan 2022 | Biotechnology, Medical | Early Stage Venture | Seoul, Seoul-t'ukpyolsi, South Korea |
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.